ImmuCell
ICCC
11 hedge funds and large institutions have $1.92M invested in ImmuCell in 2015 Q2 according to their latest regulatory filings, with funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.
24% more capital invested
Capital invested by funds: $1.55M → $1.92M (+$377K)
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
8% less funds holding
Funds holding: 12 → 11 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$41.9K |
| 2 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$15.1K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$920 |
| 4 |
Morgan Stanley
New York
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
-$45.8K |
| 2 |
SRC
Shufro Rose & Co
New York
|
-$10.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.75K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
-$2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HP
1
HealthInvest Partners
Stockholm,
Sweden
| $854K | +$15.1K | +2,200 | +2% |
|
|
SRC
2
Shufro Rose & Co
New York
| $388K | -$10.3K | -1,500 | -3% |
|
|
3
Renaissance Technologies
New York
| $217K | +$41.9K | +6,100 | +28% |
|
|
EFS
4
Essex Financial Services
Essex,
Connecticut
| $187K | – | – | – |
|
|
SKK
5
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $155K | -$45.8K | -6,663 | -25% |
|
|
6
Vanguard Group
Malvern,
Pennsylvania
| $81K | -$2.75K | -400 | -4% |
|
|
7
UBS Group
Zurich,
Switzerland
| $18K | -$1.64K | -238 | -9% |
|
8
Bank of America
Charlotte,
North Carolina
| $16K | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $7K | +$920 | +134 | +19% |
|
|
10
Creative Planning
Overland Park,
Kansas
| – | -$2K | -310 | Closed |
|
|
11
Morgan Stanley
New York
| – | +$7 | +1 | +20% |
|
ICCC Hedge Fund Activity: Q2 2015 in Review
11 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2015, worth a combined $1.92M — up 24% from $1.55M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ICCC and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $41.9K. The largest seller was Shepherd Kaplan Krochuk, cutting an estimated $45.8K.
- 11 institutional investors held ImmuCell (ICCC) as of Q2 2015, down from 12 in Q1 2015.
- Funds reported $1.92M of ImmuCell stock for Q2 2015, up 24% quarter-over-quarter.
- 0 funds opened new ImmuCell positions in Q2 2015 and 1 closed out, a net change of -1 holder.
- The largest ImmuCell buyer in Q2 2015 was Renaissance Technologies, an estimated $41.9K added.
- The largest ImmuCell seller in Q2 2015 was Shepherd Kaplan Krochuk, an estimated $45.8K sold.
Based on aggregated 13F filings for Q2 2015.